Correction To: Rolipram and Pentoxifylline Combination Ameliorates Experimental Diabetic Neuropathy Through Inhibition of Oxidative Stress and Inflammatory Pathways in the Dorsal Root Ganglion Neurons (Metabolic Brain Disease, (2022), 37, 7, (2615-2627), 10.1007/S11011-022-01060-Y)

Correction To: Rolipram and Pentoxifylline Combination Ameliorates Experimental Diabetic Neuropathy Through Inhibition of Oxidative Stress and Inflammatory Pathways in the Dorsal Root Ganglion Neurons (Metabolic Brain Disease, (2022), 37, 7, (2615-2627), 10.1007/S11011-022-01060-Y) Publisher Pubmed

Dastgheib M¹ ; Shetabboushehri SV¹ ; Baeeri M² ; Gholami M² ; Karimi MY¹ ; Hosseini A¹

Source: Metabolic Brain Disease Published:2024

Abstract

The original version of this article unfortunately contained an error in Fig. 8 where the image of HE-stained DRG neurons was mistakenly placed. In this correction, we have now provided the corrected Fig. 8 by replacing the image of HE-stained DRG neurons with the correct image. The authors declare this inadvertent error does not affect the results and conclusion of this paper. (Figure presented.). © 2023, Springer Science+Business Media, LLC, part of Springer Nature.

Style	Citing Format
MLA	Dastgheib M, et al.. "Correction To: Rolipram and Pentoxifylline Combination Ameliorates Experimental Diabetic Neuropathy Through Inhibition of Oxidative Stress and Inflammatory Pathways in the Dorsal Root Ganglion Neurons (Metabolic Brain Disease, (2022), 37, 7, (2615-2627), 10.1007/S11011-022-01060-Y)." Metabolic Brain Disease, vol. 39, no. 1, 2024, pp. 253-254.
APA	Dastgheib M, Shetabboushehri SV, Baeeri M, Gholami M, Karimi MY, Hosseini A (2024). Correction To: Rolipram and Pentoxifylline Combination Ameliorates Experimental Diabetic Neuropathy Through Inhibition of Oxidative Stress and Inflammatory Pathways in the Dorsal Root Ganglion Neurons (Metabolic Brain Disease, (2022), 37, 7, (2615-2627), 10.1007/S11011-022-01060-Y). Metabolic Brain Disease, 39(1), 253-254.
Chicago	Dastgheib M, Shetabboushehri SV, Baeeri M, Gholami M, Karimi MY, Hosseini A. "Correction To: Rolipram and Pentoxifylline Combination Ameliorates Experimental Diabetic Neuropathy Through Inhibition of Oxidative Stress and Inflammatory Pathways in the Dorsal Root Ganglion Neurons (Metabolic Brain Disease, (2022), 37, 7, (2615-2627), 10.1007/S11011-022-01060-Y)." Metabolic Brain Disease 39, no. 1 (2024): 253-254.
Harvard	Dastgheib M et al. (2024) 'Correction To: Rolipram and Pentoxifylline Combination Ameliorates Experimental Diabetic Neuropathy Through Inhibition of Oxidative Stress and Inflammatory Pathways in the Dorsal Root Ganglion Neurons (Metabolic Brain Disease, (2022), 37, 7, (2615-2627), 10.1007/S11011-022-01060-Y)', Metabolic Brain Disease, 39(1), pp. 253-254.
Vancouver	Dastgheib M, Shetabboushehri SV, Baeeri M, Gholami M, Karimi MY, Hosseini A. Correction To: Rolipram and Pentoxifylline Combination Ameliorates Experimental Diabetic Neuropathy Through Inhibition of Oxidative Stress and Inflammatory Pathways in the Dorsal Root Ganglion Neurons (Metabolic Brain Disease, (2022), 37, 7, (2615-2627), 10.1007/S11011-022-01060-Y). Metabolic Brain Disease. 2024;39(1):253-254.
BibTex	@article{ author = {Dastgheib M and Shetabboushehri SV and Baeeri M and Gholami M and Karimi MY and Hosseini A}, title = {Correction To: Rolipram and Pentoxifylline Combination Ameliorates Experimental Diabetic Neuropathy Through Inhibition of Oxidative Stress and Inflammatory Pathways in the Dorsal Root Ganglion Neurons (Metabolic Brain Disease, (2022), 37, 7, (2615-2627), 10.1007/S11011-022-01060-Y)}, journal = {Metabolic Brain Disease}, volume = {39}, number = {1}, pages = {253-254}, year = {2024} }
RIS	TY - JOUR AU - Dastgheib M AU - Shetabboushehri SV AU - Baeeri M AU - Gholami M AU - Karimi MY AU - Hosseini A TI - Correction To: Rolipram and Pentoxifylline Combination Ameliorates Experimental Diabetic Neuropathy Through Inhibition of Oxidative Stress and Inflammatory Pathways in the Dorsal Root Ganglion Neurons (Metabolic Brain Disease, (2022), 37, 7, (2615-2627), 10.1007/S11011-022-01060-Y) JO - Metabolic Brain Disease VL - 39 IS - 1 SP - 253 EP - 254 PY - 2024 ER -

Style

Citing Format

MLA

Dastgheib M, et al.. "Correction To: Rolipram and Pentoxifylline Combination Ameliorates Experimental Diabetic Neuropathy Through Inhibition of Oxidative Stress and Inflammatory Pathways in the Dorsal Root Ganglion Neurons (Metabolic Brain Disease, (2022), 37, 7, (2615-2627), 10.1007/S11011-022-01060-Y)." Metabolic Brain Disease, vol. 39, no. 1, 2024, pp. 253-254.

APA

Dastgheib M, Shetabboushehri SV, Baeeri M, Gholami M, Karimi MY, Hosseini A (2024). Correction To: Rolipram and Pentoxifylline Combination Ameliorates Experimental Diabetic Neuropathy Through Inhibition of Oxidative Stress and Inflammatory Pathways in the Dorsal Root Ganglion Neurons (Metabolic Brain Disease, (2022), 37, 7, (2615-2627), 10.1007/S11011-022-01060-Y). Metabolic Brain Disease, 39(1), 253-254.

Chicago

Dastgheib M, Shetabboushehri SV, Baeeri M, Gholami M, Karimi MY, Hosseini A. "Correction To: Rolipram and Pentoxifylline Combination Ameliorates Experimental Diabetic Neuropathy Through Inhibition of Oxidative Stress and Inflammatory Pathways in the Dorsal Root Ganglion Neurons (Metabolic Brain Disease, (2022), 37, 7, (2615-2627), 10.1007/S11011-022-01060-Y)." Metabolic Brain Disease 39, no. 1 (2024): 253-254.

Harvard

Dastgheib M et al. (2024) 'Correction To: Rolipram and Pentoxifylline Combination Ameliorates Experimental Diabetic Neuropathy Through Inhibition of Oxidative Stress and Inflammatory Pathways in the Dorsal Root Ganglion Neurons (Metabolic Brain Disease, (2022), 37, 7, (2615-2627), 10.1007/S11011-022-01060-Y)', Metabolic Brain Disease, 39(1), pp. 253-254.

Vancouver

Dastgheib M, Shetabboushehri SV, Baeeri M, Gholami M, Karimi MY, Hosseini A. Correction To: Rolipram and Pentoxifylline Combination Ameliorates Experimental Diabetic Neuropathy Through Inhibition of Oxidative Stress and Inflammatory Pathways in the Dorsal Root Ganglion Neurons (Metabolic Brain Disease, (2022), 37, 7, (2615-2627), 10.1007/S11011-022-01060-Y). Metabolic Brain Disease. 2024;39(1):253-254.

BibTex

@article{ author = {Dastgheib M and Shetabboushehri SV and Baeeri M and Gholami M and Karimi MY and Hosseini A}, title = {Correction To: Rolipram and Pentoxifylline Combination Ameliorates Experimental Diabetic Neuropathy Through Inhibition of Oxidative Stress and Inflammatory Pathways in the Dorsal Root Ganglion Neurons (Metabolic Brain Disease, (2022), 37, 7, (2615-2627), 10.1007/S11011-022-01060-Y)}, journal = {Metabolic Brain Disease}, volume = {39}, number = {1}, pages = {253-254}, year = {2024} }

RIS

TY - JOUR
AU - Dastgheib M
AU - Shetabboushehri SV
AU - Baeeri M
AU - Gholami M
AU - Karimi MY
AU - Hosseini A
TI - Correction To: Rolipram and Pentoxifylline Combination Ameliorates Experimental Diabetic Neuropathy Through Inhibition of Oxidative Stress and Inflammatory Pathways in the Dorsal Root Ganglion Neurons (Metabolic Brain Disease, (2022), 37, 7, (2615-2627), 10.1007/S11011-022-01060-Y)
JO - Metabolic Brain Disease
VL - 39
IS - 1
SP - 253
EP - 254
PY - 2024
ER -

Science Communicator Platform

Authors

Abstract